NIIMBL is pleased to announce “Inline Spiking Method for Validation of Virus Clearance in Continuous Bioprocessing” has been named the winner of NIIMBL’s inaugural Project Impact Award. The award is given annually as recognition of a Project Call Project exemplifying technical ingenuity, partnership and lasting industry impact. The award will be presented on June 25, 2026, at the NIIMBL National Meeting during the Closing Banquet and Award Ceremony.
Led by Principal Investigator Andrew Zydney of Penn State University, the project collaborators also included NIIMBL members MilliporeSigma, Genentech, and Merck. This partnership between academia and industry reflects the kind of teamwork and innovation NIIMBL strives to foster in strengthening domestic biopharmaceutical manufacturing.
“This project demonstrates how NIIMBL’s collaborative model identifies industry challenges and creates and demonstrates solutions that advance biopharmaceutical manufacturing,” said Kelvin Lee, Institute Director. “The selection committee recognized the foundational nature of this project, as well as its durability and industry adoption over time. This project is a blueprint for the kind of impact possible through NIIMBL’s Project Call work.”